Stockscreener 앱 받기
0.00
100.00%
-14.84
시간 외 거래:
14.95
14.95
+
전일 마감가:
$14.84
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$2.20B
수익:
-
순이익/손실:
$-174.61M
주가수익비율:
0.00
EPS:
-1.97
순현금흐름:
$-165.54M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$15.06
89 Bio Inc Stock (ETNB) Company Profile
명칭
89 Bio Inc
전화
(415) 432-9270
주소
655 MONTGOMERY STREET, SAN FRANCISCO, CA
Compare ETNB vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ETNB
89 Bio Inc
|
0.00 | 2.20B | 0 | -174.61M | -165.54M | -1.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
486.03 | 126.21B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
790.81 | 82.64B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
756.76 | 47.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.07 | 44.15B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
314.36 | 35.08B | 4.98B | 69.60M | 525.67M | 0.5198 |
89 Bio Inc Stock (ETNB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-04 | 재개 | H.C. Wainwright | Buy |
| 2025-03-14 | 개시 | Goldman | Neutral |
| 2025-03-13 | 개시 | Citigroup | Buy |
| 2025-02-04 | 개시 | Wolfe Research | Outperform |
| 2024-04-22 | 재개 | BofA Securities | Buy |
| 2024-01-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2023-08-28 | 개시 | UBS | Buy |
| 2023-06-13 | 개시 | Evercore ISI | Outperform |
| 2022-05-12 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-12-20 | 개시 | H.C. Wainwright | Buy |
| 2021-10-26 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-07-29 | 재개 | BTIG Research | Buy |
| 2021-05-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2021-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-10-19 | 개시 | Raymond James | Strong Buy |
| 2020-09-25 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-07-31 | 개시 | Piper Sandler | Overweight |
| 2020-07-23 | 개시 | BTIG Research | Buy |
| 2020-07-07 | 개시 | Chardan Capital Markets | Buy |
| 2019-12-09 | 개시 | BofA/Merrill | Neutral |
| 2019-12-09 | 개시 | Oppenheimer | Outperform |
| 2019-12-09 | 개시 | RBC Capital Mkts | Outperform |
| 2019-12-09 | 개시 | SVB Leerink | Outperform |
모두보기
89 Bio Inc 주식(ETNB)의 최신 뉴스
Will 89bio Inc. stock go up in YEAR2025 Trade Ideas & AI Powered Buy/Sell Recommendations - mfd.ru
Is 89bio Inc. impacted by rising ratesDollar Strength & High Accuracy Trade Alerts - mfd.ru
Precision Trading with 89bio Inc. (ETNB) Risk Zones - Stock Traders Daily
Is 89bio Inc. stock attractive for ETFsProfit Target & Consistent Growth Equity Picks - bollywoodhelpline.com
Update Report: What is BSGMs revenue forecastMarket Rally & AI Powered Market Entry Strategies - baoquankhu1.vn
The Truth About 89bio Inc: Is This Silent Biotech Sleeper About To Explode? - AD HOC NEWS
Is 89bio Inc. stock supported by innovation pipelineEarnings Risk Report & Reliable Trade Execution Plans - ulpravda.ru
How 89bio Inc. stock compares to market leadersMarket Sentiment Report & Verified Momentum Stock Ideas - Улправда
Why 89bio Inc. stock attracts global investors2025 Momentum Check & Fast Gaining Stock Reports - Улправда
89bio, Inc. (ETNB) Stock Analysis: Exploring a Potential 104.68% Upside in the Biotech Sector - DirectorsTalk Interviews
Is 89bio Inc. stock dividend yield sustainableWeekly Risk Report & Verified Momentum Watchlists - ulpravda.ru
How 89bio Inc. stock compares to growth peers2025 Key Highlights & AI Powered Market Trend Analysis - Улправда
Aug Sectors: Is 89bio Inc. stock dividend yield sustainableWeekly Trade Report & Expert Curated Trade Setup Alerts - Улправда
Will 89bio Inc. stock recover faster than peersJuly 2025 Action & Free Fast Entry Momentum Trade Alerts - Улправда
Downgrade Watch: How 89bio Inc. stock compares to growth peers2025 Macro Impact & Daily Risk Controlled Trade Plans - Улправда
[EFFECT] 89bio, Inc. SEC Filing - Stock Titan
89bio Acquisition Finalized: Roche Completes Takeover () - aktiencheck.de
[Form 4] 89bio, Inc. Insider Trading Activity - Stock Titan
Fatty liver disease companies' multibillion-dollar deals mean fatter wallets - The Business Journals
ETNB CEO Form 4 details Roche deal payout and option treatment - Stock Titan
ETNB officer reports tender offer completion; shares exchanged for $14.50 + CVR - Stock Titan
[POSASR] 89bio, Inc. SEC Filing - Stock Titan
Roche Holdings completes acquisition of 89bio and delists company from Nasdaq - Investing.com
Roche completes 89bio deal; ETNB holders get $14.50 cash + CVR - Stock Titan
89bio acquired by Roche with $14.50 cash and up to $6 CVR - Stock Titan
Roche purchases shares in tender offer for 89bio, Inc - The Manila Times
Roche (OTCQX: RHHBY) accepts 60.49% of 89bio shares, plans merger at $14.50 + CVR - Stock Titan
89bio, Inc.(NasdaqGM: ETNB) dropped from S&P Biotechnology Select Industry Index - MarketScreener
Roche Holding AG completed the acquisition of 89bio, Inc. in a tender offer transaction. - MarketScreener
ETNB CFO option exercises update direct holdings to 339,295 shares - Stock Titan
[SC TO-T/A] 89bio, Inc. Amended Third-Party Tender Offer | ETNB SEC FilingForm SC TO-T/A - Stock Titan
89bio, Inc. (ETNB) Stock Analysis: Exploring A Potential 97.97% Upside In Biotechnology - DirectorsTalk Interviews
Will 89bio Inc. stock split attract more investorsTrade Analysis Report & Safe Entry Zone Tips - Trung tâm Dự báo KTTV quốc gia
How strong is 89bio Inc. stock balance sheetEarnings Risk Summary & Fast Moving Stock Watchlists - Trung tâm Dự báo KTTV quốc gia
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (NasdaqETNB), Barinthus Biotherapeutics plc (NasdaqBRNS), Verint Systems Inc. (Nasdaq - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Combining price and volume data for 89bio Inc.Layoff News & Long-Term Growth Stock Strategies - newser.com
Will 89bio Inc. stock benefit from AI adoption2025 Geopolitical Influence & Weekly Top Performers Watchlists - newser.com
89bio, Inc. (ETNB) Stock Analysis: Unveiling A 97% Potential Upside In The Biotech Sector - DirectorsTalk Interviews
Janus Henderson Reports 5,378,185 Shares, 3.6% Stake in 89bio - Stock Titan
89bio Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc.ETNB - Business Wire
Investors Purchase High Volume of Put Options on 89BIO (NASDAQ:ETNB) - Defense World
After courting 14 pharmas, 89bio was left between a Roche and hard place in buyout talks - Fierce Biotech
Roche commences tender offer for all shares of 89bio, Inc. - GlobeNewswire
$20.50 Per Share Deal: Roche Makes Move to Acquire 89bio in Major Biotech Tender Offer - Stock Titan
89bio, Inc. (ETNB) Shareholders to Receive Up to $3.5B Total in Roche Buyout Deal - MSN
Roche commences tender offer for all shares of 89bio, Inc. for $14.50 per share in cash, plus a non-tradeable contingent value right for up to $6.00 per share in cash - Yahoo Finance
Kala Bio Stock Just Plunged 89% Today – Here’s What Happened - Stocktwits
Why 89bio Inc. stock is rated strong buy2025 Biggest Moves & Verified Entry Point Detection - newser.com
Technical analysis overview for 89bio Inc. stock2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
Is 89bio Inc. stock attractive for retirement portfoliosWeekly Stock Report & Momentum Based Trading Ideas - newser.com
89 Bio Inc (ETNB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.90%
2.73%
자본화:
|
볼륨(24시간):